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This endeavor describes the development of a paren-
teral admixture program in a l75-bed pediatric acute care 
hospital. It begins with a description of the advantage to 
the hospital of a parenteral admixture program as compared 
to conventional floor stock systems. Some examples of 
other admixture programs are cited along with specific 
characteristics of programs that could be applicable to any 
hospital. An outline is presented of the basic steps found 
in all programs. 
A detailed description is given illustrating how the 
program was actually developed in this hospital. This des-
cription includes items such as: 
1) how space for the additive center was procured; 
2) how a prediction of the workload was arrived at; 
3) how the equipment for the center was procured; and 
4) how the pilot study was set up. 
This is followed by a protocol for the admixture pro-
gram. 
A discussion of data obtained during the development 
of this program includes: 
1) how the I. V. useage rate of each unit \vas obtained; 
2) how the amount of capital loss due to the floor 
stock I. V. system was determined; 
3) the amount of capital and the square feet of stor-
age space tied up by the floor stock systems; 
4) the amount of time saved in the hospital by the 
additive system; and 
5) an evaluation of how mDny personnel in the hospital 
were rC'qllired per 100 I.V. solutions used before 
and after the addi ti vc sys tr'm. 
The last chapter discusses the effectiveness of the 
admixture program based on previously established para-
meters. Some of the conclusions reached are as follows: 
1) The program did save the hospital money through 
more efficient use of time and equipment. 
a) Capital tied up in floor stock was greatly 
reduced. 
b) The program reduced the number of man-hours 
required to operate the I.V. therapy function 
in the hospital. This freed the nurses more 
from medication problems and gave them more 
time for bedside patient care. 
e) Checks were made to insure accuracy and also 
more care was taken in following established 
hospital policies regarding parenteral therapy 
as a result of the program. 
d) Solutions and medications were all labeled 




The trend in hospital pharmacy today has seemed to be 
to attempt to increase the responsibilities of the pharma-
cist so that he might reach a point where his long academic 
training would somewhat equal his responsibilities on the 
job. The hospital pharmacist today has not been satisfied 
with the pparmacist's traditional duties and he has set out 
to become a more clinically involved member of the health 
team. Some new innovations that have come about in the 
last decade ( so are radiopharmacy, unit dose, clinical 
pharmacy, and parenteral admixture programs centralized in 
the pharmacy. A parenteral admixture program is the pri-
mary concern of this endeavor. 
The first question encountered when a superior was 
confronted regarding the establishment of a new program was, 
"Why do you b ieve such a program to be a valuable asset 
to the hospital system?" The advantages of such an additive 
1 program have been reported by authors such as Brown, 
Gallelli,2 Latiolas,3 Moravec,4 Ragland,5 Ravin,6 Schwartz,7 
8 Skolaut, and others. 
Some of the basic advantages pointed out were: 
1. The pharmacy provided a better working environment 
for preparation of parenteral solutions. The additive 
2 
centc:x' prc'r1 decl a low traffic area an it staff could work 
wi th no int·:)rruptions. The nursi:lg station typically pro-
vided a higi traf s area with the nurse frequently being 
interrupted while prepari parenteral solutions. 
2. The pharmacJs t, and not the nurse, vias trained 
specifically in such areas as chemistry and drug incompati-
bility. It always has been the pharmacist's role to pre-
pare and dispense medications. The role of the nurse has 
been to provide patient care, 
3. The additive system has reduced floor stock inven-
tory to a minimum. Therefore the hospital would not have 
such a large a!i:ount of capi tal investment in parenteral 
solutions. A~so the floor space necessary for storage of 
the solut ons would be reduced. 
The literature available clef"rly indicated that this 
function should normally be carrieJ out by the pharmacy 
staff. 
There were several examp s of parenteral admixture 
programs in the literature. These ranged widely in com-
plexity and expense. All programs followed basically the 
same steps in filling an order and mo~t had the same basic 
equipment. 
One such system was that by St. Lukes Medical Center 
in Phoenix, Arizona. 9 From the following steps one could 
easily see that their procedure was qui 
required a good deal of paper work. 
complex and 
1. A direct copy of the physician's ordcp was received 
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and checked fc;' compatibili ty and correctness. 
2. The ol"der was trans ferred onto an I. V. trans crip-
tion record fOY'TI'j, This was a preprinted form allowing the 
pharmacist to merely check off the para~eters involved in 
the order. Iters such as type solution, volume needed, 
and flow rate were checked. Many ather items such as time 
of administration were usually found on such forms as well. 
A disadvantage of this type of form was that it didn't 
lend itself to a total patient medication profile system 
since each solution usually had to occupy a separate form. 
If a profile was maintained a second transcription had to 
be made onto the profile. 
3. A name tag containing the patient's name and room 
number was then placed on a manilla foJder. The I.V. trans-
cription record was placed in the folder with a copy of the 
physician's order. 
4. A four-part I.V. communication tag was prepared 
for each parenteral admixture needed for the next 24-hour 
period. These tags were then placed in the patient's folder. 
5. An NCR two-part profile card was then prepared 
for that patient's therapy and this was placed in the 
patient's folder. 
To this point four different types of paperwork had 
been handled and no order had been fil d as yet. 
6. If there was a piggyback order a drug and dosage 
schedule had to be prepared. 
7. Upon sending the first I.V. solution to the floor 
~ 
the four-part form filled out in step number 4 was utiJizc~. 
A. The white copy was placed back in the patient's 
folder. 
B. The yellow copy was retained and later counted 
for daily record purposes. 
C. The blue and gold copies which served as labels 
were placed on the container being sent to the 
floor. 
8. The NCR portion of the profile card was sent to 
the floor to be placed in the patient's chart. 
9. When the first bottle was administered the blue 
copy of the four-part form was returned to the pharmacy with 
the following informGtion. 
A. When the infusion was started 
B. Date 
C. Administered by 
D. Hour 
E. Flow rate 
The gold copy remained on the bottle as a label. 
10. Information on the blue tag was transcribed onto 
the patient's profile form when the blue tag was returned 
to the pharmacy. This served as their charge record for 
the patient. 
11. Another four-part form was completed based on the 
information received from the blue copy of the previous 
four-part form. This was utilized for the next solution by 
placing this form in a time slot. The correct time was 
5 
calculated from the information received on the previous 
blue tag. 
This was n fine procedure but it could have been very 
cumbersome to follow ,-"hen rushed. If one person failed to 
send the proper form at the proper time all was lost. Also 
the procedure would have been very complicated for a new 
employee to learn. 
Another procedure was followed by Ohio State University 
H . t ' 10 OSpl a..L. This procedure was one that many institutions 
would find expensive since special forms were used and the 
computer was utilized for billing and label typing. 
Some innovations used by Ohio State were as follows: 
1. IThe physiciaL's order form was divided into two 
sections, the left side of the sheet was for routine orders 
and instructions and the right side WaS for medicatioll 
orders. The medication section was divided into blocks of 
three lines each. The physician was instructed to write 
one order in each block. 
2. The pharmacy received a direct copy of this order. 
The copy was a pregummed label that could be placed directly 
onto a patient's medication profile. This eliminated time 
and possible error in transcription. 
11 One more interesting idea was reported by Klotz. 
His hospit pharmacy utilized a report sheet filled out by 
the nursing unit just prior to report at 7 a.m. each morn-
ing. This sheet ccntained the following information: 
nursing station, date, time, patientts name, type of solu-
6 
tion and additives, flow rate, and amount of fluid remainin~ 
in the bottle at that time. This gave the pharmacy an up-
to-date report each day on the solutions that were being 
utilized at that time. This could be checked against the 
profile in the pharmacy to note discrepancies such as wrong 
flow rate, etc. 
Other procedural type descriptions were available in 
the literature such as those reported by Ravin,12,13 
Kenna~14 Paoline l5 and others. 16 ,17 However, the basic 
procedures drawn from these programs seemed to indicate the 
following basic steps in carrying out a parenteral admixture 
procedure: 
1. A form had to be devised to provide the pharmacy 
with an original copy of the physician's order. 
2. Steps had to be taken to insure that the order 
would be rapidly transported to the pharmacy and that the 
solution would be rapidly delivered to the nursing unit. 
3. A system of storing the orders in an organized 
manner had to be developed in the pharmacy. This would 
have to facilitate easy retrieval both by the patient's name 
or by the time the order was due on the nursing unit. 
4. A complete medication profile had to be developed 
so that a patient's total parenteral therapy and drug ther-
apy could be reviewed in a short time. 
5. Equipment had to be purchased to insure a sterile 
area for the extemporaneous preparation of parenteral solu-
tions and other sterile products. 
6. An area had to be dssiCncd to house the needed 
equipment to c(j.rry out the program. 
7. The pharmacy had to design an adequate billing 
system to insure than no charges would be lost. 
7 
8. Drug compatibility and stability information would 
have to be collectod. 
The purpose of this endeavor was to estab sh a paren-
teral admixture program in a 175-bed pediatric acute care 
hospital. 
l. The design had to be such that it would operate 
homogeneously with the unit dose and clinical pharmacy pro-
grams already in operation. 
2. The system had to include a drug compatibility 
information file. 
3. It had to include a complete patient medication 
profile. 
4. It had to supply all intravenous solutions and all 
medications added to those solutions whether added to the 
primary solution or added intermittently. 
5. This system had to promote better patient care 
through solving many problems inherent in the floor stock 
system of handling parenteral products available at that 
time. 
6. It had to save the hospital money through morc 
efficient use of time and equipment. 
As mentioned above, the present system of supplying 
parenteral solutions to the nursing units was a conventional 
8 
floor stock system. r:I'he pharmacy merely replaced the solu-
tions at each nursing station on a daily basis as they were 
used. 
This floor stock system had been unable to alleviate 
several problems that potentially were solvable by an addi··· 
tive system centralized in the pharmacy. 
1. All solutions administered by the nurse were not 
necessarily double checked before they were administered to 
the patient. It was definitely possible for a nurse to 
give a solution other than the one ordered by the physician. 
An additive program would, therefore, provide a double 
check before th2 solution left the pharmacy, a third check 
by the nurse, and a fourth check by our clinical pharmacist 
at ast every 24 hours. 
2. Solutions were sometimes not administered at the 
rate prescribed by the physician. These situations would 
immediately be noticed under an additive program and cor-
rected if a second solution was needed sooner than the pre-
scribed time or if too much solution remained when the 
second solution arrived for administration. This would 
promote closer attention to this problem by the hospital 
staff. 
3. The nursing personnel were not changing adminis-
tration sets every 24 hours according to hospital policy. 
The additive system would insure that this would be done by 
affixing the required sets to the first bottle received by 
each patient each day. 
9 
4. Many intermittent medications, especially anti-
biotics, presented problems of incompatibi ty and stability 
that the nursing staff could not be expected to understand. 
By utilizing an additive program the ph~rmacy would become 
the center of such information. 
5. The hospital policy dictated that any child under 
four years of age was not to rec ve a solution for I.V. 
administration larger than 250 cc. in volume. This would 
easily be controlled by an additive program. 
6. Nurses would have more time for actual patient care 
if the task of I.V. preparation was removed from their realm 
of responsibility. 
7. The central intravenous additive program would 
remove large volumes of floor stock solutions which take up 
valuable storage space on the nursing units. 
8. It would decrease the amount of lost charges found 
to exist in the present floor stock system of distribution. 
9. It would decrease the financial commitment to 
inventory through the removal of excess floor stocks. 
10. Solutions administered to patients were sometimes 
improperly labeled or were not labeled at all. The pharmacy 




In order to plan for the establishment of the paren-
teral program those involved had to be aware of how large 
the program was going to be when it was completed. It was 
necessary to know the number of solutions used by each 
nursing unit on a daily basis. A survey was conducted from 
November 1, 1972 to December 1) 1972. This was done by 
recording all floor stock I.V. solutions sent to each nurs-
ing unit on a daily basis. The solutions were recorded 
according to type of solution and volume of solution so 
that the us :age rates of each type of solution could be 
learned. 
From this and a subsequent time study it'was found 
that approximately 4.87 hours per day would be required to 
staff the program at the use age level that was found to 
exist. The determination of this data will be discussed in 
the next chapter. 
The program was scheduled to begin with no extra staff 
and it would continue until the workload necessitated hir-
ing more individuals. 
The next problem was that of placement of the physical 
plant for the additive center. Several areas were con-
sider2d but it was decided to keep the additive center 
11 
within tIle eXisting pharmacy area. It was decided that 
with a smaJ-l amount of rearrangement there would be ample 
space for the additive center. The reasons that it was 
decided to keep the center within the boundaries of the 
existing pharmacy are as follows: 
1. The expens would be less if the additive center 
was kept in the pharmacy. The hospital would not lose 
space in any other area to provide for this service. 
2. The center would work more homoceneously with 
other programs in the pharmacy if it was kept in close 
proximity to those programs. 
3. It would be less expensive to staff the additive 
center if all members of the pharmacy staff worked in the 
same area. 
The additive center was placed in what was part of the 
pharmacy stock room. This was a clean area and there would 
be very little traffic to interrupt work in that area. 
Since the parenteral solutions were already stocked in 
the pharmacy they were placed in the additive center. All 
stock normally occupying that area was moved to other parts 
of the pharmacy. 
Figure 1 is a diagram of the finished additive area in 
relation to the remainder of the pharmacy. 
Before purchasing a laminar flow sterile work area, 
specifications were drawn that would be suitable for the 
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Figure 1. Diagram of Additive Center in Relation to 
Remainder of Pharmacy Work Areas 
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Heigh of !:Jork tab Ie 30 to 42" 
Depth of work table - - - - - - 20 to 24" 
Width of work tal: Ie 60" 
Height of wo:d{ Sp2. e 35 to 40" 
Height of entire unit - - - 76" 
A horizcntal flow unit was chosen for two reasons. 
1. Horizontal flow units were less expensive. 
2. Vertical flow units required more precise sterile 
technique since one could not work directly above the object 
of attention or the laminar air flow past that object would 
be interrupted. 
The laminsr flow unit purchased m~t all the previous 
specifications set as Guidelines. 
One nursing unit w&S decided upon for a pilot study. 
This unit had the highest useage and the staff seemed the 
most interested in promoting such a program. While waiting 
for the laminar flow hood to arrive, a study was done on 
this unit to determine if the pharmacy staff could accur-
ately project how many solutions a patient would require on 
a daily basis based on the physician's order. This was done 
using the procesure designed for the actual pilot study. 
This procedure is discussed in detail later in this chap-
ter. The procedure was carried out exactly as if the phar-
macy was responsible for supplying the I.V. solutions 
although no solutions were actually sent during this study. 
A check of the accuracy of these projections was made using 
the floor stock records of what each patient actually 
14 
received. 
DoinB this study prior to the actual pilot study facil-
itated perfecting the procedure to a finer degree before it 
was depended upon to function in actual practice. 
Before the arri of the laminar flow hood it was 
learned that the ho:pital planned to open a new semi-
intensive care nursing unit. The date set for its opening 
was very near the date scheduled for the beginning of the 
pilot study for the pare~teral admixture program. Since 
the staff was hand picked it was decided to do the pilot 
study on this unit rather than on the unit previously 
selected. 
The pilot study began the same day that the new unit 
opened. The procedur~ ~ ilized in carrying cut the additive 
program was as follows: 
Parenteral Admixture Procedure Outline 
1. The physician has written an order for a parenteral 
solution. 
2. The order was transported to the pharmacy. This was 
done via messenger service or via nursing staff on the 
unit. 
3. rrhe order was checked for clarity and completeness. It 
was also checked for any incompatibilities that might 
exist. 
4. The order was transcribed onto the pro Ie sheet (Fig-



















































































































































































































































































































































































































Instruct ien;:;', :'or i nt Profile 
------, -- .. _-_. --_. 
(1.) ,,"atient' s na 1il8. (2.) Patjent' sage. (3.) Patient's 
nursing unit. (4.) This column indicated when sets were 
sent and how many. The number of sets was to be written on 
the same line as tho solution with wh~ch the sets were to 
be utilized. By checking this column other staff members 
could determine whether sets had been sent for that 24-hour 
period or not. (5.) This column indicated the date that 
particular solution was started. (6) N/C meant do not 
charce for that bottle. This was used when an order was 
merely written down to indicate the patien had received a 
bottle from another source such as surgery. It was also 
used when a physician's order was copied down for future 
reference. (7.) The numeral .in this section indicated 
that the bottle was sent by the pharmacy and should be 
charged for. (8.) IndicLted the type of solution used. 
(9.) Indicated the volume of solution used. (10.) Indi-
cated the flow rate prescribed. (11.) Indicated the time 
span the bottle was to run. (12.) Indicated any additives 
to the primary bottle. (13.) Clarifying remarks. 
17 
not in use. 
5. A blue-colored time file card was prep&red with the 
patient's name and nursing unit (Figure 3). This was 
filed according to the next time a solution was to be 
prepared. The solutions were prepared and sent to the 
nursing unit one hour before the solution was to be 
administered. 
A. Several steps were followed in preparing a solution. 
1). The correct solution was obtained and placed 
inside tbe sterile work area in the hood. 
2). All ingredients needed to complete the order 
were added and ~ blue-colored metal cap signi-
fying additives was seale onto the bottle. 
No blue-capped I.V. solution was to appear on 
the nursing units or b~ administered to any 
patient without a proper pharmacy-prepared 
label beil attached. 
3). A label was properly typed (Figure 4) and 
affixed upside-down onto the container leaving 
the manufacturer's solution name visib It 
was not possible to have the nurses check the 
pharmacy's accuracy if they could not read the 
manufacturer's label. If Dextrose 5% in 0.2% 
Sodium Chloride was prepared from a different 
solution such as Dextrose 5% in Sterile Water 
the amount of sodium chloride added in milli-
equivalents was noted on the label. This also 
NAML 
NSG UNIT 
Figure 3. Time File Card 
PRIMARY CHILDREN'S HOSPITAL 
Salt Lake City, Utah 
Name John Doe 
Room No. 5 so. Date 7-7~77 
Solution Dex. 5% in 0.2% N.S. 
Bottle No. 250 cc. 
Medications KCL 5 meg./250 cc. 
(NaCl 8.5 meg. added £er 250 cc. 
of D 5 w to make D 5 0.2% N.S.) 
Run From 10 am ,To ~3 __ p_m ________ _ 
Rate of Flow 50 cc./hr. 
Figure 4. I.V. Solution Label 
18 
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enabled the nursing staff to check the accuracy 
of the pharmacy (Figure 4). 
4). The necessary information was entered on the 
profile in pencil and the profile was filed 
a~jhabetically. The time card was filed accord-
ing to the time the next solution was needed. 
6. An order for a parenteral solution was considered valid 
until it "i;-las cbanged or disc:ontinue(l by the physician. 
7. All solutions were sent according to age. Any child 
under four years of age was not to receive a solution 
containing more than 250 cc. in volume. Children over 
four years of age could receive up to 500cc. in any 
one cc:;tainer. 
8. No solution was to be administered for more than 24 
hours. At that time it was to be changed whether it 
was empty or not. 
9. Administration sets were sent every 24 hours. The sets 
were sent with the first solution to be administered 
during the 7 am to 3:30 pm shift. Specific types of 
administration sets were provided for each patient. 
The type of administration set that was sent was depend-
ent upon whether the patient was on gravity drip or on 
an administration pump. There were also specific sets 
sent for patients on hyperalimenation solution. 
10. When sets or solutions were returned for credit they 
were lined out with a yellow marker on the profile to 
indicate they were not to be charged for. Only those 
20 
solutions were credited that could be used for other 
patients. Others were discarded and no credit was 
gi ven unlesf) it was pharmacy's mist8 t ::e that it was sent. 
11. All persons working in the add_;_ti ve center were to date 
all containers when they were opened. In the case of 
reconstituted medications the date, time, and final con-
centration were entered on the container. 
12. The blue-colored additive cap was not to be removed 
until immediately prior to the use of the solution. 
13. Each morning the nurses would fill out an I. V". solution 
record. This had to be checked each mOl:'!1ing in the 
additive center to keep up-to-date on the actual amount 
of solut.ion each patient had utilized during the night 
(FigurE- 5). 
14. The hood was scrubbed each morning and each evening with 
benzalkoni 1)_;:1 chloride 1; '750. Bacterial growth in the 
hood was monitored at least monthly by cultures taken 
by the laboratory. 
15. Solutions that were returned unused were periodically 
checked for sterllity by the laboratory. This procedure 
allowed the staff to cheek their sterile technique on a 
regular basis. 
Intermittent Additive Procedure 
1. The record of intermittently added medications was to be 
kept on the opposite side of the I.V. solution profile 
(Figure 6). The medication, strength, route, and signa 
To be filled j:l [lcul'atcly :H:d ::lellt to toLe rharmncy Dt t.he end of the 
7 A.H. r;'lI'3C,':; rep0I't. This wIll o]low ph:.11'm3cy to mcnitor patient 
I.V. 's ~or 211 :10'TS. Thank you. 
Data: 
Nursing StaticI!: 




. _____ ._____ .1..-_________ . ___ "-________ '-___ • _____ _ 
Figure 5. Pharmacy I.V. Solution Record 
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Figure 6. Intermittent Medication Profile 
were entered on the profile. The directions for mixing 
reconstituted medications were placed on the second line 
under signa. That particular day's date was placed 
under "S" on the pro ;_':1 Ie . The date started and date to 
be stopped were placed in their respective blocks. The 
hours of the day the medication was to be given was 
indicated by circling the appropriate time blocks 
across from the medication. As each order was filled 
the person f~lling the order would put his initials 
inside the circle indicating that th~ order had been 
filled nnd by whom. 
2 . White time file cards were used for intermit tc-nt medica-
tions. They were filed in the same manner as the blue 
I. V. solution cards., one hour before the med-ication was 
due. 
3. Those additives that had long expiration dates were sent 
for a 24-hour period. Those that had shorter expiration 
dates were sent only a few minutes before the time for 
administration. During the evening shift all medications 
were drawn up for the remainder of the night. These 
were sent to the floor and stored in the refrigerator. 
4. All medications were labeled with the patient's name, 
room number, medication name, strength, amount, date and 
time mixed, expiration date, and the amount of solution 
the medication was to be mixed with in the metriset. 
5. Crediting procedures were the same as with I.V. solutions. 
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To make 16 bottles: 
1. A 1,000 ce. bottle of Sterile Water was used and a por-
tion was discarded to make the volume approximately 
921.6 cc. 
2. The following incredients were added: (yie Ids 980 cc.) 
A. 20 cc. of NaCl (3 meq./cc.) 
B. 8.0 cc. of MgS04 (50%) 
c. 30.4 cc. of K2P04 (2 meq./cc.) 
3. A "McGaw" V 1900 series set was added to this bottle. 
(The tubing was clcLmped off and the drip chamber 
depressed before inserting; this drew out the fluid from 
the air inlet tube of the bottle when the drip chamber 
was released after insertion into the bottle. This 
eliminated any drip when the bottle was inverted.) The 
bottle was then inverted and hung inside the hood. 
4. 61.25 cc. of this solution was then added to each of 16 
empty evacuated 250 cc. sterile containers. 
5. 50 cc. of Fre Amine 8.5% was then added to each bottle, 
bringing the total volume to 111.25 cc. 
6. 130 cc. of dextrose 50% was then added to each bottle, 
bringing the total volume to 241.25 cc. 
7. Each bottle was then shaken to insure that all ingredi-
ents were mixed. 
8. 5 cc. of calcium gluconate 10% was added to each bottle. 
This brings the total volume to 246.25 cc. 
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9. A label wns attached upeide down on the cont~iner (Fig-
ure 7). Tbe date prepn.rel~ VIas ·::ntered in the upper 
right hand corner s;, :,;:1ped in red. The patient' s nt;~me 
and the date ~ent to the floor were added as they were 
sent to the nursing unit. 
10. Another label was adde:-; to the top of the container 
giving final instructions to finish preparation of the 
solution. This label gave all extra ingredients that 
were to be added. The reason for leaving out some 
electrolytes was to give the physician some flexibility 
in prescribing electrolytes based on the child's needs. 
The vitamin preparation was left out because it was 
thought tLat they would not be stablc if stored for any 
length of time (Figure 8). 
11. Two 0.2 micron fi10ers were sent with each bottle of 
hyperalimentatlon solution to the nursing unit. 
12. The following sets were sent with each hyperalimenta-
tion solution: 
A. one pediatric set 
B. one metriset with float 
C. one extension set 
13. No more than 24-hour supply was sent at anyone time. 
The solutions and sets were changed every 24 hours. 
14. The solutions were stored in the pharmacy for 30 days 
under refrigeration and then discarded. Each batch was 
cultured after 7 days in the refrigerator and cultured 
again when discarded. 
Fre Amine Hyperalimentation 
(Full Strength) 
Supplies 0.884 cal/ml of solution 
Each 250 cc contains: 
Free Amine 8.5% 50 cc 
Dextrose 50% 130 cc 
221 Non-protein cal. meq Sodium 
16.57 Protein ,- ale meq Potas s i urn 
2 meq ~!agnesil1 3.75 meq Phosphate 
2 . 4 me q Cal c i u L: 1 . 2 5 c c MV I con c . 
2.4 meq Glucon~ ~e 2 meq Sulfate 
6 meq Chloride 8.5 meq Acetate 
Protein Equivalent 3.9 gm 
Nitrogen Content 0.625 gm 
355 Non-protein cal. per 1 gm Nitrogen 
Name Date 
Figure 7. Sample Hyperalimentation Label 
THIS BOTTLE CONTAINS: 
Na 4.25 meq 
K 3.80 meq 
TO MAKE THE REGULAR FORi,lULA ADD: 
1) 1.25 cc Na Acetate 3 meq/cc 
yielding Na 8 meq total. 
2) 1.25 cc K Acetate 3 meq/cc 
yielding k 7.55 meq total. 
3) 1.25 cc MV'! Concentrate. 
For any deviation in Na or K 
merely change the amount of NaAc 
or KAc to be added. For assistance 
see formula book on IV table. 
PLEASE ~~KE NECESSARY ADDITIONS ON 
THE IV LABEL . .... . 
Figure 8. Sample Instruction Label 
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15. The fi shed solution it! s considered expired after 24 
hours whether refrigerated or not. It was immediately 
discarded and no credit was given if it was not used. 
The pilot study was carried on with no floor stock on 
the nursing uni t during pharmacy hou·'s. During the hours 
the pharmacy \lIas closed a minimal floor stock was left on 
the floor with the following sign-out sheet (Figure 9). 
PLEASE SIGN OUT FOR ANY SOLUTIONS USED 








Dextrose 5% in Water 
pat i en t 's n am e 
patient's name 
pa tien t' s name 
Figure 9. Sample Floor Stock Sign-Out Sheet 
Each morning the floor stock was returned to the phar-
macy by the messenger. Any solutions that were used were 
restocked and the patient for whom it was used was charged 
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on the I.V. profile. 
This procedure forced the nursing staff to rely on the 
pharmacy during the pharmacy hours. The nursing staff soon 
realized that the pharmacy could efficiently supply their 
needs and the system began to run smoothly. 
The only extra duty the nurses hall to perform when the 
program began was to fill out the I.V. solution record at 
7 a.m. each morning just before the change of shift report 
(Figure 5). The nurses found that this was no extra duty) 
in fact, because it merely put into wr2"ting what was already 
being transmitted by word of mouth during report. In fact, 
they began making two copies, one for the pharmacy and one 
for the nursing staff. 
This meant the nursing staff had been relieved of the 
responsibil:i ty of preiJaring parenteral solutions and had 
not been given any extra work to take its place. 
After two months the pharmacy expanded its staff 
slightly and expanded the addi ti ve program '".0 another uni t. 
The expansion in staff required no extra money for the 
salary budget. Several circumstances enabled the pharmacy 
to expand its staff without expanding its budget. 
The first event that took place was that the nursing 
philosophy of the hospital Changed. The philosophy changed 
from that of having one medication nurse give all medica-
tion to that of each nurse supplying her own patient's total 
needs. This change in philosophy phased out most of the 
medication nurse's responsibility and left her with about 
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four hours per d tot ak eon 0 t h (; r d uti e s . \AJh e nth e me d i -
cation nurse ori. nated she was paid by the pharmacy budget 
as part of the unit dose program. As soon as she was 
phased out of her medication duties on the nursing units, 
the pharmacy began to utilize her as an I.V. technician. 
She is checked by a pharmacist and performs much the same 
duties in the pharmacy that she previously performed on the 
nursing units. 
To staff the weekends a student was hired for 16 hours 
from money not yet utilized in the salary budget. 
This staffing h&s thus far been sufficient to carry 
the workload in the additive center. 
III 
DISCUSSION OF DATA 
The original survey to determine how many solutions 
were used per day per uni t and what type: solutions were used 
most frequently was carried on from November 1, 1972 to 
December 1, 1972. This study was carried on throughout the 
entire hospit 
The average number of patients that month was found to 
be 112. The lowest number was 75 and the highest number 
was 144. This compared to the normal yer'.rly average of 108. 
The following data represent the results of that study. 
Nursing I.V. 's I.V. 's SolIn. Vol. Avg. Amt. Unit Total Per Day Most Used (cc. ) 
5 w. 235 7.8 D5 0.2 N.S. 500 112 
leU 99 3.3 D5 Isolyte P 250 33 
Nursery 84 2.8 D5 Isolyte P 250 54 
4 So. 224 7.5 D5 Isolyte P 500 175 
4 w. 428 14.3 D5 Isolyte P 250 109 
The average total number of I.V. solutions per day was 36. 
Approximately 50% of all solutions were found to con-
tain at least one additive. 
The average patient on I.V. therapy receives approxi-
mately 3 bott s per day. This means that 36 solutions per 
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day represent about 12 persons on . V. therapy per d::y. 
It was determined that 7 of those 12 persons received 
at least one intermittent medicatiGn four times daily. It 
was also determined that 4 of those 7 peI>sons recei ved at 
least two intermittent medications 4 times daily. 
This was determined easily by merely recording how 
many persons receiving I.V. solutions also received I.V. 
medications and how many I.V. medications each received via 
the unit dose program. 
It was determined by a time study that the average 
time spent on an I.V. solution was about 3.6 minutes. This 
included record~ng, mixing, and labeling and any time neces-
sary to keep up with ch& ,.,·s made on the orders on t:re unit. 
To prepare an intermi ttf'nt medication took about 3.7 min-
utes. This also included recording, mixing, and label .g. 
From the statements made above the following calcula-
tions can be made for a 24-hour period: 
36 solutions x 3.6 minutes/solution = 129.6 minutes 
7 persons x 4 medications/day = 28 medications 
4 persons x 4 additional meds/day = 16 meds 
28 medications + 16 medications = 44 intermittent meds/ 
day 
44 intermittent medications x 3.7 minutes/med = 162.8 
minutes 
129.6 minutes + IG2.8 minutes = 292.4 minutes = 4.87 
hours 
It took 4.87 hours per day to staff the program at the 
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workload indicated by these studies. This was aJl the 
information necessary to predict the workload on an average 
daily basis. Messenger time was not calculated since a 
messenger servil.,e alrt> existed under the jur';,sdictlon of 
the pharHlclcy. 
The next survey done was designed to determine whether 
revenue was being lost in excessive amounts due to the 
floor stock i"ystcm of distributing I. V. solutions in exis-
tance at that time. 
It was determined that an average of $85.00 per month 
was lost during 1971 and $73.00 per month during 1972. 
This w~s done by going over old floor stock records 
for those ,'ears. By adding all floor stock charge slips 
received fur a given month and subtracting that total from 
the total amount of floor stock sent to the floor for that 
month, the loss was determined. 
An inventory was taken to determine how many dollars 
worth of floor stock was being maintained on each nursing 
station. A determination of how many square feet was uti-
lized in each area was also made. The results were as 
follows: (see top of page 33) 
The total capital tied up in floor stock was $182.90. 
The total capital spent in the cost of I.V. solutions for 
30 days normal average use was $515.00. Floor stock plus 
the capital used to keep floor stock maintained for 30 days 
was then calculated to be $695.90. The average monthly 


























that approximately 11.3% of the money spent on I.V. solu-
tions was lost due to lost charges. This was considered 
sign -t fi cant. 
Thc' tot amount of apace used on the nursing units 
for L) torage of I. V. floor stock was found to be 29.7 sq. 
ft. No cost per sq. ft. of storage space was availab 
A detailed survey was cB,rried on by the nursi:lg staff 
on a particular nursing unit before the additive program was 
in operation In that area. It was found that the average 
time spent by the nurses on this station on I.V. medications 
waJ approximately 32 minutes per day. The time spent on 
I.V. solutions and additives directly to those solutions \\Tas 
found to be approximately 25 minutes per day. Therefore the 
total time spent on this unit per day on parenteral therapy 
was approximately 57 minutes. This was compared \\Tith 
another study done on the same nursing unit after the 
admixture program became fully operable on that unit. The 
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results of time sp nt after the program was G.5 min~~es per 
day on I. V. medications a' ,j 5.5 minutes per day on solu-
tions and thei::" addi ti ves. The totaJ time spent was found 
to be 12 minutes per day. 
The total number of patients per day O~l this uni t is 
graphed for each study (Figure 10). 
Another study was done to determine the average per-
cent of the total patients on this nursing unit that had 
parenteral t\erapy. The average percent of patients 
recei ving p(;~rcnteral therapy was found to be 20.8% of the 
total number of patients on that unit. 
Total time spent was correlated with the above percent 
of the total number patients on the nursing U' t on a daily 
basis for each stud~. The resultf; were as follows: 
Time spent/parenteral therapy ratient bei'ore the 
admixture program 14.25 minutes. 
Time spent/parenteral therapy patient after the 
admixture program 3.26 minutes. 
A survey was taken before and after the parenteral 
admixture program to determine as completely as possible 
how many full-time employees were required to handle I.V. 
solutions. The following is the result of that survey: 
Before After 
_Procurement 0.5 hr/day 0.3 hr/day 
Nursing 5.0 hr/day 1.0 hr/day 
Pharmacy 3.0 hr/da:l 4.9 hr/da:l 
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By centrQlizini~ the addi ti ve program in the pharmacy 
the nun~er of hours per day required to handle parenteral 
therapy was decreased. 
Wi th all the information gathered abc:t:e it was deter-
mined that the equi valent of one full-time employee \'Jas 
required to hand ~70.5 I.V. solutions per 7 days before 
the admixture and 234.2 I.V. solutions wiJh the admixture 
program. Anotl1er way of expres~)ing this data was to say 
that 59.2% of one full-time employee was required to handle 
the work load produced by 100 I.V. solutions per 7 days 
before the admixture program and 4 .1% of one full-time 
employee was required per 100 solutions with the admixture 
prog.i'am. 
IV 
RESULTS AND CONCLUSIONS 
In the first chapter several goals were set for the 
program tJ accomplish. It was decided to discuss each of 
those go s or proposals in this chapter for the purpose of 
concluding whether or not the program actually accomplished 
what it was established to do. 
1. The parenteral admixture program had to operate 
homogeneously with the unit dose and clinical pharmacy pro-
grams already in operation. 
The I.V. uitive profilt: was incorporated into the 
unit dose prof_Ie. The pharmacy then had a complete record 
of all the p&tients' medications in three separate sections. 
r:ehe first secti·:'n was for I. V. solutions and additives 
directly to those solutions. The second section was for all 
intermittent medications given I.V. and the third was for 
all other medications. The pharmacist in charge of unit 
dose was also in charge of checking the technician filling 
I.V. solution orders. Therefore he was aware of how both 
systems were functioning at all times. This pharmacy has 
dealt with the parenteral admixture program as an extension 
of the unit dose program. 
These two systems together have supplied the clinical 
pharmacist with a complete drug profile with which she can 
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doub ly ins ure th<..:.t the patient is recei ving proper thera[,\' 
in both medications and parenteral solutions. 
2. rrhe program had to include 0. drug i::;ompatibility 
informatlon file. This file was COltlY)sed of several drug 
incompatibility fi s which were found in the literaiure at 
the time the program was developed. Also included was 
incompatibility information compiled as the result of an 
extensive literature search by this author. The bibliogra-
phy contains the sources of this informat '_:'In. 27-59 
3. The admixture program had to include a complete 
medi cation profile. This has beel! accomplished as was 
pointed out in #1 cbove. 
4. It had to supply all intravenous solutions and all 
medications auded to those solutions whether added to the 
primary bottle or added interoittently. 
The pharmacy now supplies all solutions and I.V. medi-
cations to the nursing units on the additive ! rogram during 
the hours the pharmacy is open. Just before closing all 
I.V. solutions and medications are sent that have been 
ordered for the remainder of the night. The only times that 
items were needed fronl floor stock was on new orders or 
order changes that occured after the pharmacy closed. 
5. The admixture program had to save the hospital 
money through more efficient use of time and equipment. 
The program removed a large volume of floor stock 
amounting to about $150.00. This also reduced expensive 
storage space to a minimum. 
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Since all solutions and I.V. medications were charged 
for before they left the pharmacy t!~(: lost charges were 
reduced to a minimum. The only source of a lost charge 
would have been through forgetting to make an entry on the 
patient's profile. This was checked by two people, making 
this occurance highly unlikely. 
Floor stock was checked daily under the admixture pro-
gram and answers were sought for any unexplained absence of 
floor stock. This reduced floor stock loss to a minimum. 
Since floor stock was actually very minimal under this sys-
tem~ it was a simple task to monitor it's use. 
According to survey taken before and aft r the admix-
ture program:ls . n operation" th number of man-hours 
required to operate the parenteral therapy function 
decreased. This decrease meant that the nurse was then 
freed from some medication time due to the more efficient 
program and could then spend more time with bedside patient 
care. 
6. This system had to promote better patient care 
through solving many problems that the floor stock system 
could not solve. The rather nebulous term "patient care" 
was hard to evaluate so the following parameters thought to 
contribute to patient care were evaluated. 
A. All solutions administered prior to the paren-
teral admixture program were not double 
checked. Under the additive system the accu-
racy of the preparation was checked by two 
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persons be fore the solution 1t' f't the pharmacy. 
A third check took place when the nurse admin-· 
istcred tLe solution. 
B. Solutions \',IE'.<!·':: s~.metimes not administered 
strictly at the rate ordered by the physician. 
The pharmacy sent solutions to the nursing 
units at predetermined times calculated 
according to the fJow rate ordered by the 
physician. If solutions were needed earlier 
or later than those times a check was' made to 
determine the reason. This insured that the 
patient was receiving the prescribed amount 
of e. :)lution. 
C. Adn::. 1listration set.·~ were sometimes not 
changed every 24 hours according to hospital 
policy. The admixture program insured that 
sets were changed a~ proper intervals because 
they were sent by the pharmacy affixed to a 
container. The patient had to receive a new 
set at the time that container was used. 
D. There were incompatibility and stability 
problems about which the nursing staff had no 
information. Since the pharmacy added all 
the medications and premixed all intermittent 
medications such problems were screened for 
before the medications reached the nursing 
uni ts . Any medi cat ions wi th unus l~al charac-
teris tics were l;-lheled \'1i th precautionary 
labels when necessary. 
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E. Hospital policy dictated that no chil~ under 
fO:,lr yeol'E of age tva.~) 4,0 rece:':"iC-; a ,'301ution 
for I.V. administration larger than 250 cc. 
in volume. Under the old floor :tock system 
this policy was not strictly adhered to. 
Nurses many times administered 500 cc. solu-
tions to children under four to avoid frequent 
changing of bottles when the patient was 
receiving large volumes of solution per hour. 
Uncler the nc'w addi ti ve system the pharmacy 
simply sent solu:ions according to hospital 
policy. This forced strict adherence to the 
hospi t;, 1 's poli cy. 
F. Solutions administered to patients were some-
times improperly labeled or not labeled at 
all. The pharmacy's additive system insured 
that a proper and uniform label was attached 
to each solution before leaving the pharmacy. 
This meant that each nursing unit in the 
hospital had only one type of label and the 
information on the label was presented in a 
uniform manner. This was of advantage to 
housestaff, attending physicians and nurses 
working on more than one nursing unit. 
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